Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 809103, 6 pages
http://dx.doi.org/10.1155/2014/809103
Research Article

Clonotypic Analysis of Immunoglobulin Heavy Chain Sequences in Patients with Waldenström’s Macroglobulinemia: Correlation with MYD88 L265P Somatic Mutation Status, Clinical Features, and Outcome

Hematology Section of First Department of Propaedeutic Medicine, National and Kapodistrian University of Athens Medical School, Laikon Hospital, Agiou Thoma 17, 11527 Athens, Greece

Received 18 April 2014; Accepted 12 July 2014; Published 14 August 2014

Academic Editor: Gerassimos Pangalis

Copyright © 2014 Loizos Petrikkos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. G. Owen, S. P. Treon, A. Al-Katib et al., “Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia,” Seminars in Oncology, vol. 30, no. 2, pp. 110–115, 2003. View at Google Scholar
  2. S. H. Swerdlow, E. Campo, N. L. Harris et al., WHO Classification of Tumours of Haematipoetic and Lymphoid Tissues, IARC Press, Lyon, France, 2008.
  3. S. P. Treon, Z. R. Hunter, A. Aggarwal et al., “Characterization of familial Waldenström's macroglobulinemia,” Annals of Oncology, vol. 17, no. 3, pp. 488–494, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. S. D. Wagner, V. Martinelli, and L. Luzzatto, “Similar patterns of Vκ gene usage but different degrees of somatic mutation in hairy cell leukemia, prolymphocytic leukemia, Waldenstrom's macroglobulinemia, and myeloma,” Blood, vol. 83, no. 12, pp. 3647–3653, 1994. View at Google Scholar · View at Scopus
  5. H. Aoki, M. Takishita, M. Kosaka, and S. Saito, “Frequent somatic mutations in D and/or JH segments of Ig gene in Waldenstrom's macroglobulinemia and chronic lymphocytic leukemia (CLL) with Richter's syndrome but not in common CLL,” Blood, vol. 85, no. 7, pp. 1913–1919, 1995. View at Google Scholar · View at Scopus
  6. G. A. Pangalis, M. Kyrtsonis, F. N. Kontopidou et al., “Differential diagnosis of Waldenstrom's macroglobulinemia from other low-grade B-cell lymphoproliferative disorders,” Seminars in Oncology, vol. 30, no. 2, pp. 201–205, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Stamatopoulos, C. Belessi, C. Moreno et al., “Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations,” Blood, vol. 109, no. 1, pp. 259–270, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Gachard, M. Parrens, I. Soubeyran et al., “IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas,” Leukemia, vol. 27, no. 1, pp. 183–189, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. S. S. Sahota, F. Forconi, C. H. Ottensmeier et al., “Typical waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events,” Blood, vol. 100, no. 4, pp. 1505–1507, 2002. View at Google Scholar · View at Scopus
  10. S. H. Walsh, A. Laurell, G. Sundström, G. Roos, C. Sundström, and R. Rosenquist, “Lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia derives from an extensively hypermutated B cell that lacks ongoing somatic hypermutation,” Leukemia Research, vol. 29, no. 7, pp. 729–734, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Kriangkum, B. J. Taylor, S. P. Treon, M. J. Mant, A. R. Belch, and L. M. Pilarski, “Clonotypic IgM V/D/J sequence analysis in Waldenstrom macroglobulinemia suggests an unusual B-cell origin and an expansion of polyclonal B cells in peripheral blood,” Blood, vol. 104, no. 7, pp. 2134–2142, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Martín-Jiménez, R. García-Sanz, A. Balanzategui et al., “Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance,” Haematologica, vol. 92, no. 5, pp. 635–642, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. R. A. Rollett, E. J. Wilkinson, D. Gonzalez et al., “Immunoglobulin heavy chain sequence analysis in Waldenström's macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance,” Clinical Lymphoma and Myeloma, vol. 7, no. 1, pp. 70–72, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. S. P. Treon, L. Xu, G. Yang et al., “MYD88 L265P somatic mutation in Waldenström's macroglobulinemia,” The New England Journal of Medicine, vol. 367, no. 9, pp. 826–833, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Xu, Z. R. Hunter, G. Yang et al., “MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction.,” Blood, vol. 121, no. 11, pp. 2051–2058, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Jiménez, E. Sebastián, M. C. Chillón et al., “MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia,” Leukemia, vol. 27, no. 8, pp. 1722–1728, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Poulain, C. Roumier, A. Decambron et al., “MYD88 L265P mutation in Waldenstrom macroglobulinemia,” Blood, vol. 121, no. 22, pp. 4504–4511, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Varettoni, L. Arcaini, S. Zibellini et al., “Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms.,” Blood, vol. 121, no. 13, pp. 2522–2528, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Willenbacher, E. Willenbacher, A. Brunner, and C. Manzl, “Improved accuracy of discrimination between IgM Multiple Myeloma and Waldenström Macroglobulinaemia by testing for MYD88 L265P mutations,” British Journal of Haematology, vol. 161, no. 6, pp. 902–904, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. S. L. Ondrejka, J. J. Lin, D. W. Warden, L. Durkin, J. R. Cook, and E. D. Hsi, “MYD88 L265P somatic mutation: its usefulness in the differential diagnosis of bone marrow involvement by B-cell lymphoproliferative disorders,” The American Journal of Clinical Pathology, vol. 140, no. 3, pp. 387–394, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. S. P. Treon and Z. R. Hunter, “A new era for Waldenstrom macroglobulinemia: MYD88 L265P,” Blood, vol. 121, no. 22, pp. 4434–4436, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Yang, Y. Zhou, X. Liu et al., “A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenstrom macroglobulinemia,” Blood, vol. 122, no. 7, pp. 1222–1232, 2013. View at Google Scholar
  23. P. Morel, A. Duhamel, P. Gobbi et al., “International prognostic scoring system for Waldenström macroglobulinemia,” Blood, vol. 113, no. 18, pp. 4163–4170, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. J. J. M. van Dongen, A. W. Langerak, M. Brüggemann et al., “Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936,” Leukemia, vol. 17, no. 12, pp. 2257–2317, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Matsuda, E. K. Shin, H. Nagaoka et al., “Structure and physical map of 64 variable segments in the 3' 0.8-megabase region of the human immunoglobulin heavy-chain locus,” Nature Genetics, vol. 3, no. 1, pp. 88–94, 1993. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Varettoni, S. Zibellini, D. Capello et al., “Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors,” vol. 54, pp. 2485–2489, 2013. View at Publisher · View at Google Scholar
  27. A. Hadzidimitriou, A. Agathangelidis, N. Darzentas et al., “Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases,” Blood, vol. 118, no. 11, pp. 3088–3095, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. A. A. Warsame, H. Aasheim, K. Nustad et al., “Splenic marginal zone lymphoma with VH1-02 gene rearrangement expresses poly- and self-reactive antibodies with similar reactivity,” Blood, vol. 118, no. 12, pp. 3331–3339, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Zibellini, D. Capello, F. Forconi et al., “Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma,” Haematologica, vol. 95, no. 10, pp. 1792–1796, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Algara, M. S. Mateo, M. Sanchez-Beato et al., “Analysis of the IgVH somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course,” Blood, vol. 99, no. 4, pp. 1299–1304, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Arcaini, S. Zibellini, F. Passamonti et al., “Splenic marginal zone lymphoma: clinical clustering of immunoglobulin heavy chain repertoires,” Blood Cells, Molecules, and Diseases, vol. 42, no. 3, pp. 286–291, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Kalpadakis, G. A. Pangalis, E. Dimitriadou et al., “Mutation analysis of IgVH genes in splenic marginal zone lymphomas: correlation with clinical characteristics and outcome,” Anticancer Research, vol. 29, no. 5, pp. 1811–1816, 2009. View at Google Scholar · View at Scopus
  33. J. Kriangkum, B. J. Taylor, M. J. Mant, S. P. Treon, A. R. Belch, and L. M. Pilarski, “The malignant clone in Waldenstrom's macroglobulinemia,” Seminars in Oncology, vol. 30, no. 2, pp. 132–135, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. R. N. Damle, T. Wasil, F. Fais et al., “Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia,” Blood, vol. 94, no. 6, pp. 1840–1847, 1999. View at Google Scholar · View at Scopus
  35. T. J. Hamblin, Z. Davis, A. Gardiner, D. G. Oscier, and F. K. Stevenson, “Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia,” Blood, vol. 94, no. 6, pp. 1848–1854, 1999. View at Google Scholar · View at Scopus
  36. A. Krober, T. Seiler, A. Benner et al., “VH mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia,” Blood, vol. 100, no. 4, pp. 1410–1416, 2002. View at Google Scholar · View at Scopus
  37. S. Stilgenbauer, L. Bullinger, P. Lichter, and H. Döhner, “Genetics of chronic lymphocytic leukemia: genomic aberrations and VH gene mutation status in pathogenesis and clinical course,” Leukemia, vol. 16, no. 6, pp. 993–1007, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Sahota, G. Babbage, and N. Weston-Bell, “CD27 in defining memory B-cell origins in Waldenström's macroglobulinemia,” Clinical Lymphoma and Myeloma, vol. 9, no. 1, pp. 33–35, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. E. E. Manasanch, R. Braylan, M. Stetler-Stevenson et al., “Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphoma,” Leukemia and Lymphoma, vol. 55, pp. 1402–1403, 2013. View at Publisher · View at Google Scholar